Suppr超能文献

亚洲重度春季角结膜炎儿童的类固醇性高眼压症

Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis.

作者信息

Ang Marcus, Ti Seng-Ei, Loh Raymond, Farzavandi Sonal, Zhang Rongli, Tan Donald, Chan Cordelia

机构信息

Singapore National Eye Centre, Singapore.

出版信息

Clin Ophthalmol. 2012;6:1253-8. doi: 10.2147/OPTH.S32936. Epub 2012 Aug 3.

Abstract

BACKGROUND

We describe clinical characteristics and risk factors for corticosteroid response in children with severe vernal keratoconjunctivitis (VKC).

DESIGN

Retrospective, noncontrolled, comparative case series.

PARTICIPANTS

Patients from three tertiary centers in Singapore.

METHODS

We reviewed patients with severe VKC (clinical grade > 2) who were on topical steroid therapy, with a minimum follow-up period of 1 year post-presentation. Logistic regression was used to determine risk factors for corticosteroid response.

MAIN OUTCOME MEASURE

Corticosteroid response was defined as intraocular pressure (IOP) >21 mmHg (three consecutive readings), or a rise of more than 16 mmHg from baseline, after commencement of steroid therapy in the absence of other possible causes of raised IOP.

RESULTS

Forty-one of 145 (28.3%) patients developed a corticosteroid response, of which eight (5.5%) progressed to glaucoma. The overall mean age of onset of VKC was 9.9 ± 4.4 years. Longer duration of corticosteroid use (OR, 5.06; 95% CI: 1.04-25.56; P = 0.45) and topical dexamethasone 0.01% (OR, 2.25; 95% CI: 1.99-5.08; P = 0.40) were associated with corticosteroid response. Mixed type of VKC (OR, 9.76; 95% CI: 3.55-26.77; P < 0.001), the presence of limbal neovascularization of ≥ three quadrants (OR, 6.33; 95% CI: 2.36-16.97; P < 0.001), and corneal involvement (OR, 3.51; 95% CI: 1.31-9.41; P = 0.012) were significant clinical risk factors after adjusting for potential confounders such as age, sex, ethnicity, duration, and type of corticosteroid used.

CONCLUSION

Children on long-term oral corticosteroids with severe, mixed-type VKC and corneal involvement are more likely to develop corticosteroid response, and may require early treatment to prevent progression to glaucoma.

摘要

背景

我们描述了重度春季角结膜炎(VKC)患儿皮质类固醇反应的临床特征和危险因素。

设计

回顾性、非对照、比较性病例系列研究。

研究对象

来自新加坡三个三级医疗中心的患者。

方法

我们回顾了接受局部类固醇治疗的重度VKC患者(临床分级>2级),就诊后至少随访1年。采用逻辑回归分析确定皮质类固醇反应的危险因素。

主要观察指标

皮质类固醇反应定义为在开始类固醇治疗后,在没有其他可能导致眼压升高的原因的情况下,眼压(IOP)>21 mmHg(连续三次测量),或较基线升高超过16 mmHg。

结果

145例患者中有41例(28.3%)出现皮质类固醇反应,其中8例(5.5%)进展为青光眼。VKC的总体平均发病年龄为9.9±4.4岁。使用皮质类固醇的时间更长(比值比[OR],5.06;95%置信区间[CI]:1.04 - 25.56;P = 0.45)和使用0.01%的局部地塞米松(OR,2.25;95% CI:1.99 - 5.08;P = 0.40)与皮质类固醇反应相关。在调整了年龄、性别、种族、使用皮质类固醇的时间和类型等潜在混杂因素后,混合型VKC(OR,9.76;95% CI:3.55 - 26.77;P < 0.001)、三个及以上象限存在角膜缘新生血管(OR,6.33;95% CI:2.36 - 16.97;P < 0.001)以及角膜受累(OR,3.51;95% CI:1.31 - 9.41;P = 0.012)是显著的临床危险因素。

结论

患有重度、混合型VKC且角膜受累的长期口服皮质类固醇的儿童更有可能出现皮质类固醇反应,可能需要早期治疗以防止进展为青光眼。

相似文献

1
Steroid-induced ocular hypertension in Asian children with severe vernal keratoconjunctivitis.
Clin Ophthalmol. 2012;6:1253-8. doi: 10.2147/OPTH.S32936. Epub 2012 Aug 3.
2
Severe vernal keratoconjunctivitis requiring trabeculectomy with mitomycin C for corticosteroid-induced glaucoma.
Clin Exp Ophthalmol. 2012 May-Jun;40(4):e149-55. doi: 10.1111/j.1442-9071.2011.02591.x. Epub 2011 Jul 26.
3
Evaluation of retinal nerve fiber layer thickness in vernal keratoconjunctivitis patients under long-term topical corticosteroid therapy.
Cutan Ocul Toxicol. 2014 Sep;33(3):184-8. doi: 10.3109/15569527.2013.829483. Epub 2013 Sep 11.
4
Steroid-induced glaucoma and blindness in vernal keratoconjunctivitis.
Br J Ophthalmol. 2020 Feb;104(2):265-269. doi: 10.1136/bjophthalmol-2019-313988. Epub 2019 May 4.
6
Vernal keratoconjunctivitis in Thailand.
Asian Pac J Allergy Immunol. 2003 Mar;21(1):25-30.
7
Ocular complications of severe vernal keratoconjunctivitis (VKC) in Yemen.
Saudi J Ophthalmol. 2011 Jul;25(3):291-4. doi: 10.1016/j.sjopt.2011.02.001. Epub 2011 Feb 16.
8
Novel Insights in the Management of Vernal Keratoconjunctivitis (VKC): European Expert Consensus Using a Modified Nominal Group Technique.
Ophthalmol Ther. 2023 Apr;12(2):1207-1222. doi: 10.1007/s40123-023-00665-5. Epub 2023 Feb 15.
9
Efficacy, Safety and Steroid-sparing Effect of Topical Cyclosporine A 0.05% for Vernal Keratoconjunctivitis in Indian Children.
J Ophthalmic Vis Res. 2019 Oct 24;14(4):412-418. doi: 10.18502/jovr.v14i4.5439. eCollection 2019 Oct-Dec.
10
Vernal keratoconjunctivitis: a severe allergic eye disease with remodeling changes.
Pediatr Allergy Immunol. 2014 Jun;25(4):314-22. doi: 10.1111/pai.12197. Epub 2014 Jan 20.

引用本文的文献

1
Mapping the Future: Anterior Segment OCT for Corneal Epithelial Thickness in Vernal Keratoconjunctivitis.
Maedica (Bucur). 2025 Mar;20(1):19-25. doi: 10.26574/maedica.2025.20.1.19.
2
Managing Bilateral Vernal Keratoconjunctivitis, Keratoconus, and Steroid-Induced Glaucoma: A Threefold Struggle.
Cureus. 2025 Jan 24;17(1):e77901. doi: 10.7759/cureus.77901. eCollection 2025 Jan.
3
Role of Serine Protease Inhibitors A1 and A3 in Ocular Pathologies.
Invest Ophthalmol Vis Sci. 2024 Feb 1;65(2):16. doi: 10.1167/iovs.65.2.16.
5
The short-term effects of intranasal steroids on intraocular pressure in pediatric population.
Int Ophthalmol. 2022 Dec;42(12):3821-3827. doi: 10.1007/s10792-022-02402-6. Epub 2022 Jul 12.
9
Vernal Keratoconjunctivitis: A Case of Anti-IgE Treatment with Short-Lasting Remission.
Case Rep Ophthalmol. 2020 Jul 3;11(2):268-275. doi: 10.1159/000508031. eCollection 2020 May-Aug.
10
Local delivery of corticosteroids in clinical ophthalmology: A review.
Clin Exp Ophthalmol. 2020 Apr;48(3):366-401. doi: 10.1111/ceo.13702. Epub 2020 Jan 22.

本文引用的文献

1
Severe vernal keratoconjunctivitis requiring trabeculectomy with mitomycin C for corticosteroid-induced glaucoma.
Clin Exp Ophthalmol. 2012 May-Jun;40(4):e149-55. doi: 10.1111/j.1442-9071.2011.02591.x. Epub 2011 Jul 26.
3
Nonseasonal allergic conjunctivitis in the tropics: experience in a tertiary care institution.
Ocul Immunol Inflamm. 2008 Jul-Aug;16(4):141-5. doi: 10.1080/09273940802184182.
4
Ocular allergy overview.
Immunol Allergy Clin North Am. 2008 Feb;28(1):1-23, v. doi: 10.1016/j.iac.2007.12.011.
5
Clinical grading of vernal keratoconjunctivitis.
Curr Opin Allergy Clin Immunol. 2007 Oct;7(5):436-41. doi: 10.1097/ACI.0b013e3282efb726.
6
Prospective, long-term evaluation of steroid-induced glaucoma.
Eye (Lond). 2008 Jan;22(1):26-30. doi: 10.1038/sj.eye.6702474. Epub 2006 Jun 23.
7
Case series of 406 vernal keratoconjunctivitis patients: a demographic and epidemiological study.
Acta Ophthalmol Scand. 2006 Jun;84(3):406-10. doi: 10.1111/j.1600-0420.2005.00622.x.
10
Vernal keratoconjunctivitis in Thailand.
Asian Pac J Allergy Immunol. 2003 Mar;21(1):25-30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验